Methods for generating hematopoietic stem cells
AssigneeThe Brigham and Women S Hospital, Inc.
InventorDhvanit I. Shah
Life of this patent
Estimating the term…
Abstract
In some aspects and embodiments, the invention provides methods for making hematopoietic stem cells, including for HSCT. The method comprises providing a cell population comprising hemogenic endothelial (HE) or endothelial cells, and increasing activity or expression of DNA (cytosine-5-)-methyltransferase 3 beta (Dnmt3b) and/or GTPase IMAP Family Member 6 (Gimap6) in the HE and/or endothelial cells under conditions sufficient for stimulating formation of HSCs.
Claims19
1-28. (canceled)
A pharmaceutical composition comprising a cell population comprising long-term hematopoietic stem cells (LT-HSCs), wherein the LT-HSCs reconstitute to multi-lineage adult blood upon transplantation.
A pharmaceutical composition comprising a cell population comprising induced pluripotent stem cells (iPSCs) derived hematopoietic stem cells (HSCs), wherein the iPSCs-derived HSCs reconstitute to multi-lineage adult blood upon transplantation.
A method of transplanting hematopoietic stem cells (HSCs) in a subject in need thereof, the method comprising:
- providing a cell population comprising CD34+ cells;
- contacting the cell population with an effective amount of a Piezo1 agonist under conditions that form hematopoietic stem cells (HSCs) in the cell population;
- and then
- administering the cell population comprising HSCs to the subject by intravenous infusion or intra-bone marrow transplantation.
Dependencies are inferred from the claim text.